News

Sparc Technologies has appointed Alana Barlow as the inaugural chief executive officer of Sparc Hydrogen, with the company confirming her commencement on 8 December 2025.

Australian manufacturing recorded a stronger third quarter, with small and micro manufacturers increasing sales, expanding margins and reducing excess stock levels, according to the latest Unleashed manufacturing report.

Swinburne University has been awarded $526,081 from the Australian Research Council (ARC) to support new research into tunable wave metamaterials, with the funding granted under the ARC’s Discovery Early Career Researcher Award (DECRA) scheme.

Tetra Pak has acquired Latvian bioreactor specialist Bioreactors.net in a move set to advance alternative food production capabilities for Australian manufacturers.

Australia and China have formalised a new cooperation framework on steel industry emissions, with the Department of Industry, Science and Resources signing a memorandum of understanding (MoU) with China’s Ministry of Industry and Information Technology to advance joint work on steel decarbonisation.

Western Australia's manufacturing and clean energy capabilities are being placed at the centre of a three-day investment mission to South Korea, with the state government seeking to strengthen industrial and energy partnerships with one of its largest trading partners.

Lockheed Martin Australia has commenced manufacturing operations at a new Missile Assembly Facility in Port Wakefield, South Australia, marking what the company describes as a significant step in developing domestic guided-weapons capability.

ASC Pty Ltd has appointed Alex Walsh as its Acting Chief Executive Officer, with the defence and nuclear industry executive to step into the role on 12 December 2025.

Queensland is placing manufacturing at the forefront of its economic strategy, with the state government opening expressions of interest for the National Innovation Visa (NIV) as part of efforts to attract global talent and build new industries.

CSL Seqirus has officially opened its $1 billion plant in Tullamarine, described as the Southern Hemisphere’s first cell-based vaccine manufacturing facility.